The Discounted Cash Flow (DCF) valuation of Albireo Pharma Inc (ALBO) is (62.02) USD. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on DCF is -240.5%.
Based on the latest price of 44.15 USD and our DCF valuation, Albireo Pharma Inc (ALBO) is a sell. selling ALBO stocks now will result in a potential gain of 240.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.8% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (189.99) - (34.51) | (62.02) |
| Upside | -530.3% - -178.2% | -240.5% |